Multiple endocrine neoplasia type 1 is not rare in Japan

Endocrine Journal

Volumn 44, Issue 6, 1997, Pages 841-845

  Katai, Miyuki ^a   Sakurai, Akihiro ^a   Itakura, Yasunori ^a   Ikeo, Yasuto ^a   Nakajima, Koji ^a   Hara, Masahiro ^a   Iijima, Sachiko ^a   Kaneko, Tsuyoshi ^a   Kobayashi, Mutsuhiro ^b   Ichikawa, Kazuo ^a   Aizawa, Toru ^a   Hashizume, Kiyoshi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Iida Municipal Hospital   (Japan)

Author keywords

Endocrine tumors; Multiple endocrine neoplasia type 1; Prevalence

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CARCINOID; CLINICAL ARTICLE; EARLY DIAGNOSIS; GENETIC SCREENING; HUMAN; HYPERCALCEMIA; HYPERTENSION; HYPERTHYROIDISM; HYPOPHYSIS TUMOR; JAPAN; MULTIPLE ENDOCRINE NEOPLASIA; PEDIGREE ANALYSIS; PREVALENCE; RACE DIFFERENCE;

EID: 6844265561     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.44.841     Document Type: Article

References (20)

1. Brandi ML, Marx SJ, Aurbach GD, Fitzpatrick LA (1987) Familial multiple endocrine neoplasia type I: A new look at pathophysiology. Endocr Rev 8: 391-405.
2. Larsson C, Skogseid B, Öberg K, Nakamura Y, Nordenskjöld M (1988) Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332: 85-87.
3. Thakker RV, Bouloux P, Wooding C, Chotai K, Broad PM, Spurr NK, Besser GM, O'Riordan JLH (1989) Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. N Engl J Med 321: 218-224.
4. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Crabtree JS, Wang Y, Roe BA, Weisemann J, Boguski MS, Agarwal SK, Kester MB, Kim YS, Heppner C, Dong Q, Spiegel AM, Burns AL, Marx SJ (1997) Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276: 404-407.
5. Larsson C, Shepherd J, Nakamura Y, Blomberg C, Weber G, Werelius B, Hayward N, Teh B, Tokino T, Seizinger B, Skogseid B, Öberg K, Nordenskjöld M (1992) Predictive testing for multiple endocrine neoplasia type 1 using DNA polymorphisms. J Clin Invest 89: 1344-1349.
6. Kytölä S, Leisti J, Winqvist R, Salmela P (1995) Improved carrier testing for multiple endocrine neoplasia, type 1, using new microsatellite-type DNA markers. Hum Genet 96: 449-453.
7. Sakurai A, Katai M, Itakura Y, Nakajima K, Baba K, Hashizume K (1996) Genetic screening in hereditary multiple endocrine neoplasia type 1: Absence of a founder effect among Japanese families. Jpn J Cancer Res 87: 985-994.
8. Yoshimoto K, Saito S (1991) Clinical characteristics in multiple endocrine neoplasia type 1 in Japan: A review of 106 patients. Folia Endocrinol Japon 67: 764-774 (In Japanese).
9. Yoshimoto K, Kimura T (1996) Clinical features and genetic abnormalities in multiple endocrine neoplasia type 1. Folia Endocrinol Japon 72: 137 (Abstract) (In Japanese).
10. Yoshimoto K, Iwahana H, Kubo K, Saito S, Itakura M (1991) Allele loss on chromosome 11 in a pituitary tumor from a patient with multiple endocrine neoplasia type 1. Jpn J Cancer Res 82: 886-889.
11. Teh BT, Hii SI, David R, Parameswaran V, Grimmond S, Walters MK, Tan TT, Nancarrow DJ, Chan SP, Mennon J, Larsson C, Zaini A, Khalid BAK, Shepherd JJ, Cameron DP, Hayward NK (1994) Multiple endocrine neoplasia type 1 (MEN1) in two Asian families. Hum Genet 94: 468-472.
12. Shepherd JJ (1991) The natural history of multiple endocrine neoplasia type 1. Highly uncommon or highly unrecognised? Arch Surg 126: 935-952.
13. Vasen HFA, Lamers CBHW, Lips CJM (1989) Screening for the multiple endocrine neoplasia syndrome type 1. A study of 11 kindreds in the Netherlands. Arch Int Med 149: 2717-2722.
14. Sakurai A, Katai M, Furihata K, Hashizume K (1996) Gsα gene mutation may be uncommon in patients with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 81: 2394-2396
15. Marx SJ, Spiegl AM, Levine MA, Rizzoli RE, Lasker RD, Santora AC, Downs RW, Auerbach GD (1982) Familial hypocalciuric hypercalcemia. The relation to primary parathyroid hyperplasia. N Engl J Med 307: 416-427.
16. Öberg K, Skogseid B, Eriksson B (1989) Multiple endocrine neoplasia type 1 (MEN1). Clinical, biochemical and general investigations. Acta Oncol 28: 383-387.
17. Burin) to chromosome 11q: Evidence for a founder effect in patients from Newfoundland. Am J Hum Genet 54: 1060-1066.
18. Rona RJ, Beech R, Mandalia S, Donnai D, Kingston H, Harris R, Wilson O, Axtell C, Swan AV, Kavanagh F (1994) The influence of genetic counselling in the era of DNA testing on knowledge, reproductive intentions and psychological wellbeing. Clin Genet 46: 198-204.
19. Sharpe NF (1994) Informed consent and Huntington disease: A model for communication. Am J Med Genet 50: 239-246.
20. Hudson KL, Rothenberg KH, Andrews LB, Kahn MJE, Collins FS (1995) Genetic discrimination and health insurance: An urgent need for reform. Science 270: 391-393.